Electronic Health Records (EHR, EMR)
HIMSS21
AR Consultants Director Dr. Barry Newman discusses what's gone wrong with EHRs and how to get them back on the right course.
This week's top stories include Walmart choosing Epic's EHR platform for its health centers, large health insurers controlling the market in nearly three-quarters of the country, and Amazon rolling out its Halo View wearable.
While the 'robot' aspect of RPA gets most of the attention, successful implementation centers on the people and processes that will be impacted by the technology – and in a healthcare system where burnout is rampant, there are plenty of those.
HIMSS21
Virtual assistants are the future for both patients and providers, explains Dr. Yaa Kumah-Crystal, assistant professor of biomedical informatics at Vanderbilt University Medical Center.
Technology has proved to be a blessing for consumers who today have a plethora of care options and improved access to care. This is not the case with frontline providers who continue to suffer from burnout and fatigue.
Wellforce's chief digital officer and system CIO discusses the strategic opportunities – and the challenges – of moving the health system's entire Epic infrastructure and app ecosystem to AWS cloud.
Even when things go back to some semblance of normal and care teams return to their regular processes, burnout will still be felt. It's up to healthcare leaders to help manage workplace stress.
With Google Health and Apple both reported to be, respectively, closing down and scaling back their healthcare efforts, it's worth asking just how disruptive consumer technology companies can be in this hugely complex and fragmented industry.
This week's top stories include Amwell snapping up SilverCloud Health and Conversa Health, the AMA backing vaccine mandates for healthcare workers, and the VA suspending Cerner EHR rollouts until 2022.
This week's top stories include the VA flagging unreliable IT infrastructure cost estimates along with training deficiencies for its EHR modernization program, and a recently approved Alzheimer's drug that could strain Medicaid budgets.